Hidekata Yasuoka Selected Research

Antibodies

2/2022	Anti-Zo antibodies in Japanese myositis patients detected by a newly developed ELISA.
3/2007	Autoantibody response against a novel testicular antigen protein highly expressed in testis (PHET) in SSc patients.
10/2004	[A case of mixed connective tissue disease successfully treated for hemophagocytic syndrome with intermittent intravenous injection of cyclophosphamide].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hidekata Yasuoka Research Topics

Disease

11	Systemic Scleroderma (Systemic Sclerosis) 11/2023 - 12/2003
11	Immunoglobulin G4-Related Disease 01/2021 - 05/2014
11	Fibrosis (Cirrhosis) 01/2020 - 12/2005
10	Rheumatoid Arthritis 06/2023 - 09/2014
5	Connective Tissue Diseases (Connective Tissue Disease) 11/2020 - 12/2003
3	Fever (Fevers) 08/2023 - 01/2018
3	Necrosis 04/2023 - 03/2004
3	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2022 - 01/2020
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2018
3	Idiopathic Pulmonary Fibrosis 01/2019 - 11/2006
3	Mixed Connective Tissue Disease (MCTD) 01/2018 - 10/2004
3	Pulmonary Arterial Hypertension 02/2015 - 11/2013
2	Dermatomyositis (Dermatopolymyositis) 02/2022 - 10/2020
2	Lymphadenopathy 01/2021 - 01/2016
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020 - 11/2006
2	Multi-centric Castleman's Disease 12/2017 - 01/2017
2	Inflammation (Inflammations) 11/2016 - 10/2009
2	Myasthenia Gravis 12/2005 - 04/2003
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 08/2023
1	Shoulder Pain 08/2023
1	Hepatocellular Carcinoma (Hepatoma) 08/2023
1	Liver Diseases (Liver Disease) 06/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2023
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 06/2023
1	Polymyositis 02/2022
1	Muscular Diseases (Myopathy) 02/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 02/2022
1	Eosinophilia 01/2021
1	Virus Diseases (Viral Diseases) 11/2020
1	Osteoarthritis 01/2020
1	Acro-Osteolysis (Acroosteolysis) 01/2020
1	Calcinosis 01/2020
1	Synovitis 10/2019
1	Lung Diseases (Lung Disease) 01/2019
1	Disease Progression 01/2018
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 01/2018
1	Arthritis (Polyarthritis) 01/2018

Drug/Important Bio-Agent (IBA)

9	Immunoglobulin G (IgG)IBA 01/2021 - 09/2015
7	AutoantibodiesIBA 02/2022 - 12/2003
6	Methotrexate (Mexate)FDA LinkGeneric 06/2023 - 01/2015
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2003
6	CollagenIBA 01/2020 - 11/2006
6	Insulin-Like Growth Factor Binding Protein 5IBA 01/2019 - 09/2006
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
4	GlucocorticoidsIBA 01/2021 - 09/2015
4	tocilizumab (atlizumab)FDA Link 05/2020 - 01/2015
4	CytokinesIBA 10/2019 - 03/2004
4	Fibronectins (Fibronectin)IBA 01/2019 - 11/2006
4	Insulin-Like PeptidesIBA 01/2019 - 11/2006
3	Abatacept (Orencia)FDA Link 05/2023 - 09/2014
3	AntibodiesIBA 02/2022 - 10/2004
3	InterleukinsIBA 01/2021 - 03/2004
3	beta-cyclodextrin tetradecasulfate (CTDS)IBA 11/2020 - 10/2012
3	Insulin-Like Growth Factor Binding ProteinsIBA 01/2014 - 11/2006
2	Rituximab (Mabthera)FDA Link 11/2023 - 01/2018
2	C-Reactive ProteinIBA 08/2023 - 01/2018
2	Peptides (Polypeptides)IBA 05/2023 - 04/2003
2	cyclic citrullinated peptideIBA 05/2023 - 11/2020
2	interleukin-21 (interleukin 21)IBA 01/2021 - 10/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2020 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 10/2019 - 12/2017
2	Interleukin-4 (Interleukin 4)IBA 10/2018 - 09/2015
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 10/2004
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 05/2014 - 11/2013
2	Insulin-Like Growth Factor Binding Protein 3IBA 10/2009 - 01/2008
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2009 - 08/2009
2	AntigensIBA 12/2005 - 11/2004
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2004 - 12/2003
1	Bevacizumab (Avastin)FDA Link 08/2023
1	Immune Checkpoint InhibitorsIBA 08/2023
1	atezolizumabIBA 08/2023
1	golimumab FDA Link 06/2023
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 06/2023
1	Adalimumab (Humira)FDA Link 04/2023
1	Antirheumatic Agents (DMARD)IBA 04/2023
1	Ligases (Synthetase)IBA 02/2022
1	Chemokine CCL26IBA 01/2021
1	iguratimodIBA 01/2021
1	milk fat globuleIBA 01/2021
1	glucose utilization inhibitor (IGU)IBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 11/2020
1	anti-scl-70 autoantibodiesIBA 01/2020
1	Infliximab (Remicade)FDA Link 01/2020
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2020
1	anticentromere antibodyIBA 01/2020
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020
1	Interleukin-8 (Interleukin 8)IBA 10/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2019
1	Interleukin-10 (Interleukin 10)IBA 10/2019
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 05/2018
1	Immunoglobulin E (IgE)IBA 05/2018
1	Immunoglobulin M (IgM)IBA 05/2018
1	LigandsIBA 01/2018
1	CC ChemokinesIBA 01/2018
1	Vasodilator Agents (Vasodilators)IBA 01/2018

Therapy/Procedure

8	Therapeutics 08/2023 - 12/2003
1	Drug Tapering 06/2023
1	Aftercare (After-Treatment) 05/2018
1	Renal Dialysis (Hemodialysis) 01/2018